openPR Logo
Press release

Pharma Parenteral Packaging Market 2024: Trends, Analysis, And Industry Insights

05-13-2024 08:48 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: ABNewswire

Pharma Parenteral Packaging Market

Pharma Parenteral Packaging Market

Pharma Parenteral Packaging Market is valued at US$ 13.28 Bn in 2023, and it is expected to reach US$ 18.85 Bn by 2031, with a CAGR of 4.47% during the forecast period of 2024-2031.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market - By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules, Vials, Prefilled syringes, Cartridges, & Others), By Material (Glass, Polymer, PVC, Others), By Packaging Type (Small Volume Parenteral, Large Volume Parenteral) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Pharma Parenteral Packaging Market is valued at US$ 13.28 Bn in 2023, and it is expected to reach US$ 18.85 Bn by 2031, with a CAGR of 4.47% during the forecast period of 2024-2031.

Request for Sample Pages: [https://www.insightaceanalytic.com/request-sample/2446]

Pharma parenteral packaging is created to hold and transport sterile pharmaceutical goods administered through injections. These packaging techniques keep medical products safe, contamination-free, and undamaged in storage, and transit and maintain their potency.

The growing pharmaceutical sector, increasing prevalence of chronic diseases, technological advancements, demand for parenteral packaging and sterile packaging solutions, and increased pharmaceutical expenditure worldwide are driving the pharmaceutical packaging market.

However, with stringent government regulations and standards, the high cost of raw materials used in pharma parenteral packaging, such as glass and plastic, can fluctuate significantly and hamper the market's growth.

List of Prominent Players in the Pharma Parenteral Packaging Market:

* Adelphi Healthcare Packaging
* Akorn, Inc.
* Alcami Corporation, Inc.
* Amcor
* Ardena Holding NV
* Baxter International Inc.
* Becton, Dickinson and Company
* Berkshire Sterile Manufacturing
* Berry Global Inc.
* Catalent Inc.
* Gerresheimer AG
* Nipro Corporation
* PCI Pharma Services
* Schott AG
* Schur Flexibles Group
* SGD Pharma
* SiO2 Materials Science.
* Stevanato Group S.p.A
* Terumo Corporation
* UDG Healthcare Plc.
* West Pharmaceutical Services, Inc.
* Ypsomed Holding AG

Pharma Parenteral Packaging Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2023

USD 13.28 Bn

Revenue Forecast In 2031

USD 18.85 Bn

Growth Rate CAGR

CAGR of 4.47% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn, Volume (Tons) and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Drug Type, By Product Type, By Material, By Packaging Type

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Market Dynamics:

Drivers-

The growing demand for pharma parenteral packaging market is primarily fueled by the increasing popularity and penetration of generic medications coupled with blockbusters and other small-molecule drugs going off-patent globally. Packaging is crucial for safely storing and transporting medicines. Thus, pharma parenteral packaging utilization will be propelled by the increasing need for generic pharmaceuticals.

Challenges:

Stringent government regulations and standards can potentially slow innovation and increase manufacturers' costs. Pharma parenteral packaging manufacturers must comply with regulations set by agencies like the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) regarding material compatibility, sterility, and labelling.

Regional Trends:

The North American pharma parenteral packaging market is anticipated to register a significant market share in revenue. It is projected to grow at a high CAGR in the near future because of the presence of major market players, the growing pharmaceutical industry, and more demand for injectable medicine packaging. Besides, Europe had a substantial market share because of expanded vaccine programs and the number of people suffering from chronic and infectious diseases.

Curious About This Latest Version Of The Report? Enquiry Before Buying: [https://www.insightaceanalytic.com/enquiry-before-buying/2446]

Recent Developments:

* In January 2024, SCHOTT Pharma expanded its global manufacturing network and invested a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina in central Serbia.
* In Nov 2023, Amcor announced the introduction of the newest generation of its Medical Laminates products. Amcor's newest discovery makes it possible to create recyclable all-film packaging in the polyethylene stream. A mono-material polyethylene (PE) laminate is the latest packaging solution; it can be utilized for catheters, injection and tubing systems, curtains, and protective coverings.
* In October 2023, Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.
* In Nov 2022, BD developed the Effivax glass prefillable syringe to enhance biopharmaceutical manufacturing processes by running smoothly on fill/finish packaging lines. The fill/finish and container reliability of Effivax's design improvements are intended to assist the company's biopharmaceutical clients in meeting the exacting requirements of vaccine manufacture. The syringe lowers the possibility of a line halt, raises manufacturing capacity, and lowers the total cost of ownership.

Segmentation of Pharma Parenteral Packaging Market-

By Drug Type-

* Small Molecules
* Biologics
* Vaccines
* Biosimilars
* Others

By Product Type-

* Bottles
* Ampoules
* Vials
* Prefilled syringes
* Cartridges
* Others

By Material-

* Glass
* Polymer
* PVC
* Others

By Packaging Type

* Small Volume Parenteral
* Large Volume Parenteral

By Region-

North America-

* The US
* Canada
* Mexico

Europe-

* Germany
* The UK
* France
* Italy
* Spain
* Rest of Europe

Asia-Pacific-

* China
* Japan
* India
* South Korea
* South East Asia
* Rest of Asia Pacific

Latin America-

* Brazil
* Argentina
* Rest of Latin America

Middle East & Africa-

* GCC Countries
* South Africa
* Rest of the Middle East and Africa

For More Customization @ [https://www.insightaceanalytic.com/customisation/2446]

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D'Souza
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pharma-parenteral-packaging-market-2024-trends-analysis-and-industry-insights]
Country: United States
Website: https://www.insightaceanalytic.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma Parenteral Packaging Market 2024: Trends, Analysis, And Industry Insights here

News-ID: 3494715 • Views:

More Releases from ABNewswire

Total Joy Homecare Responds to Surging Demand for Senior Health Care Services in Greater Houston
Total Joy Homecare Responds to Surging Demand for Senior Health Care Services in …
Total Joy Homecare expands services to meet growing Houston demand for in-home senior care, offering non-medical support that helps families maintain independence and dignity at home. Houston's rapidly aging demographic has prompted local care provider Total Joy Homecare to expand its comprehensive support services, addressing the critical need for quality senior health care services [https://maps.app.goo.gl/hUcW1N7qWy5EdHJs5] throughout the Greater Houston area. The company's response comes as families increasingly seek reliable alternatives to
Texas Company Introduces On-Site Carrier Repair Services to Reduce Fleet Downtime
Texas Company Introduces On-Site Carrier Repair Services to Reduce Fleet Downtim …
Texas Reefer Solutions introduces mobile carrier repair services in Dallas, revolutionizing how transportation fleets handle refrigeration breakdowns by providing on-site professional repairs, eliminating route deviations, and reducing cargo-threatening delays. The transportation industry faces a significant challenge when refrigerated trucks require repairs, often forcing drivers to deviate from critical routes and schedules. Texas Reefer Solutions has emerged as a game-changing solution, introducing mobile carrier repair services [https://maps.app.goo.gl/P6nfg5WF7sckR7aZ8] that bring professional technicians directly
Family Therapy in Birmingham: How the Right Therapist Can Transform Relationships
Family Therapy in Birmingham: How the Right Therapist Can Transform Relationship …
Family therapy in Birmingham helps families improve communication, resolve conflict, and build stronger bonds. With the support of a qualified therapist near you, therapy creates a safe space to share, heal, and reconnect. Whether you're searching for therapy near me or counselling for your family, Phinity Therapy offers guidance for lasting change. Families are the foundation of our lives. They provide love, support, and connection, but they can also be the
Multiple Sclerosis Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Biogen, Immune Response BioPharma, Celgene, Novartis, Sanofi, Actelion, Bayer
Multiple Sclerosis Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Tri …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the